본문 바로가기
KERD
논문KCI 등재

Proteomic and Morphologic Evidence for Taurine-5-Bromosalicylaldehyde Schiff Base as an Efficient Anti-Mycobacterial Drug

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Mycobacterium tuberculosis, a causative pathogen of tuberculosis (TB), still threatens human health worldwide. To find a novel drug to eradicate this pathogen, we tested taurine-5- bromosalicylaldehyde Schiff base (TBSSB) as an innovative anti-mycobacterial drug using Mycobacterium smegmatis as a surrogate model for M. tuberculosis. We investigated the antimicrobial activity of TBSSB against M. smegmatis by plotting growth curves, examined the effect of TBSSB on biofilm formation, observed morphological changes by scanning electron microscopy and transmission electron microscopy, and detected differentially expressed proteins using two-dimensional gel electrophoresis coupled with mass spectrometry. TBSSB inhibited mycobacterial growth and biofilm formation, altered cell ultrastructure and intracellular content, and inhibited cell division. Furthermore, M. smegmatis adapted itself to TBSSB inhibition by regulating the metabolic pathways and enzymatic activities of the identified proteins. NDMA-dependent methanol dehydrogenase, NAD(P)H nitroreductase, and amidohydrolase AmiB1 appear to be pivotal factors to regulate the M. smegmatis survival under TBSSB. Our dataset reinforced the idea that Schiff base-taurine compounds have the potential to be developed as novel anti-mycobacterial drugs.

Abstract

Mycobacterium tuberculosis, a causative pathogen of tuberculosis (TB), still threatens human health worldwide. To find a novel drug to eradicate this pathogen, we tested taurine-5- bromosalicylaldehyde Schiff base (TBSSB) as an innovative anti-mycobacterial drug using Mycobacterium smegmatis as a surrogate model for M. tuberculosis. We investigated the antimicrobial activity of TBSSB against M. smegmatis by plotting growth curves, examined the effect of TBSSB on biofilm formation, observed morphological changes by scanning electron microscopy and transmission electron microscopy, and detected differentially expressed proteins using two-dimensional gel electrophoresis coupled with mass spectrometry. TBSSB inhibited mycobacterial growth and biofilm formation, altered cell ultrastructure and intracellular content, and inhibited cell division. Furthermore, M. smegmatis adapted itself to TBSSB inhibition by regulating the metabolic pathways and enzymatic activities of the identified proteins. NDMA-dependent methanol dehydrogenase, NAD(P)H nitroreductase, and amidohydrolase AmiB1 appear to be pivotal factors to regulate the M. smegmatis survival under TBSSB. Our dataset reinforced the idea that Schiff base-taurine compounds have the potential to be developed as novel anti-mycobacterial drugs.

참고문헌 (32)

  1. "GLOBAL TUBERCULOSIS REPORT 2018" (2018)[URL]
  2. Rîmbu C, "Antibacterial activity of Pd(II) complexes with salicylaldehyde-amino acids Schiff bases ligands", Chem. Pharm. Bull. (Tokyo), 62, pp.12~15 (2014)
  3. Chaudhary NK, "Metal complexes of a novel schiff base based on penicillin: characterization, molecular modeling, and antibacterial activity study", Bioinorg. Chem. Appl, 2017, pp.6927675~ (2017)
  4. Siddappa K, "Synthesis, spectroscopic characterization, and biological evaluation studies of 5bromo-3-(((hydroxy-2-methylquinolin-7-yl)methylene)hydrazono) indolin-2-one and its metal (II) complexes", Bioinorg. Chem. Appl, 2014, pp.483282~ (2014)
  5. Andiappan K, "In vitro cytotoxicity activity of novel Schiff base ligand-lanthanide complexes", Sci. Rep, 8(1), pp.3054~ (2018)
  6. Zhang X, "Induction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activity", Int. J. Mol. Med, 22, pp.677~682 (2008)
  7. Li L, "DNA binding, DNA cleavage and BSA interaction of a mixed-ligand copper(II)complex with taurine Schiff base and 1, 10-phenanthroline", J. Photochem. Photobiol. B, 125, pp.56~62 (2013)
  8. Ruqiang Yuan, "In Vitro Activity of Taurine-5-Bromosalicylaldehyde Schiff Base Against Planktonic and Biofilm Cultures of Methicillin-Resistant Staphylococcus aureus", Journal of Microbiology and Biotechnology, 24(8), pp.1059~1064 (2014), 한국미생물·생명공학회[DOI]
  9. Zhang W, "Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase", Int. J. Biochem. Cell Biol, 40, pp.2560~2571 (2008)
  10. Chen Y, "Deficiency of D-alanyl-D-alanine ligase A attenuated cell division and greatly altered the proteome of Mycobacterium smegmatis", MicrobiologyOpen, 3, pp.e819~ (2019)
  11. Yang S, "The biological properties and potential interacting proteins of DalanylD-alanine ligase A from Mycobacterium tuberculosis", Molecules, 23, pp.E324~ (2018)
  12. Marland Z, "Expression, purification, crystallization and preliminary X-ray diffraction analysis of an essential lipoprotein implicated in cell-wall biosynthesis in Mycobacteria", Acta crystallogr. Sec. F, Struct. Biol. Cryst. Commun, 61, pp.1081~1083 (2005)
  13. Pan F, "Cell wall core galactofuran synthesis is essential for growth of mycobacteria", J. Bacteriol, 183, pp.3991~3998 (2001)
  14. Kieser KJ, "Peptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility", Proc. Nat. Acad. Sci. USA, 112, pp.13087~13092 (2015)
  15. Rombouts Y, "Exposure of mycobacteria to cell wallinhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism", J. Biol. Chem, 287, pp.11060~11069 (2012)
  16. Alderwick LJ, "The mycobacterial cell wall--peptidoglycan and arabinogalactan", Cold Spring Harb. Perspect. Med, 5, pp.a021113~ (2015)
  17. Jankute M, "Assembly of the mycobacterial cell wall", Ann. Rev. Microbiol, 69, pp.405~423 (2015)
  18. Lewis K, "Programmed death in bacteria", Microbiol. Mol. Biol. Rev, 64, pp.503~514 (2000)
  19. Tanouchi Y, "Programmed cell death in bacteria and implications for antibiotic therapy", Trends Microbiol, 21, pp.265~270 (2013)
  20. Peters NT, "A fail-safe mechanism in the septal ring assembly pathway generated by the sequential recruitment of cell separation amidases and their activators", J. Bacteriol, 193, pp.4973~4983 (2011)
  21. Yang DC, "A conformational switch controls cell wall-remodelling enzymes required for bacterial cell division", Mol. Microbiol, 85, pp.768~781 (2012)
  22. Chauviac F-X, "Crystal structure of reduced MsAcg, a putative nitroreductase from mycobacterium smegmatisand a close homologue of mycobacterium tuberculosis Acg", J. Biol. Chem, 287, pp.44372~44383 (2012)
  23. Pitsawong W, "Mechanism-informed refinement reveals altered substrate-binding mode for catalytically competent nitroreductase", Structure, 25, pp.978~987 (2017)
  24. Cortial S, "NADH oxidase activity of Bacillus subtilis nitroreductase NfrA1 : insight into its biological role", FEBS Lett, 584, pp.3916~3922 (2010)
  25. Hektor HJ, "Identification of a magnesium-dependent NAD(P)(H)-binding domain in the nicotinoprotein methanol dehydrogenase from Bacillus methanolicus", J. Biol. Chem, 277, pp.46966~46973 (2002)
  26. Liu H, "Novel TetR family transcriptional factor regulates expression of multiple transport-related genes and affects rifampicin resistance in Mycobacterium smegmatis", Sci. Rep, 6, pp.27489~ (2016)
  27. Titgemeyer F, "A genomic view of sugar transport in Mycobacterium smegmatis and Mycobacterium tuberculosis", J. Bacteriol, 189, pp.5903~5915 (2007)
  28. Valente W, "A Kinetic Study of In vitro lysis of mycobacterium smegmatis", Chem. Eng. Sci, 64, pp.1944~1952 (2009)
  29. Agrawal P, "Use of Mycobacterium smegmatis deficient in ADP-ribosyltransferase as surrogate for Mycobacterium tuberculosis in drug testing and mutation analysis", PLoS One, 10, pp.e0122076~ (2015)
  30. Namouchi A, "Phenotypic and genomic comparison of Mycobacterium aurum and surrogate model species to Mycobacterium tuberculosis : implications for drug discovery", BMC Genomics, 18(1), pp.530~ (2017)
  31. Verma A, "Mycobacterium tuberculosis rrn promoters : differential usage and growth rate-dependent control", J. Bacteriol, 181, pp.4326~4333 (1999)
  32. Manca C, "Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro", Infect. Immun, 67, pp.74~79 (1999)

관련 논문AI추천

In Vitro Activity of Taurine-5-Bromosalicylaldehyde Schiff Base Against Planktonic and Biofilm Cultures of Methicillin-Resistant Staphylococcus aureusHouli Zhang, Li Ma, Ruqiang Yuan, Shanshan Huang, Wenli Zhang, Yuan Lin, Yunpeng Diao한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2014 · 제24권 제8호What Can Proteomics Tell Us about Tuberculosis?Elba Rogríguez-Hernández, Feliciano Milián-Suazo, Jorge Germinal Cantó-Alarcón, Susana Flores-Villalva, Yesenia Rubio-Venegas한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2015 · 제25권 제8호Host-Directed Therapeutics as a Novel Approach for Tuberculosis Treatment김예람, 양철수한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2017 · 제27권 제9호In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in Mycobacterium tuberculosis김수경, 김용식, 남궁우, 류지원, 서훈희, 송호연, 이기인, 이병의, Hafij Al Mahmud, Md Imtiazul Islam한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2017 · 제27권 제11호Anti-Mycobacterial Activity of Tamoxifen Against Drug-Resistant and Intra-Macrophage Mycobacterium tuberculosis김수경, 남궁우, 송호연, 이병의, 장웅식, Biswajit Podder, Md. Anirban Jyoti한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2015 · 제25권 제6호Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?고원중, Wing Wai Yew대한내과학회 · The Korean Journal of Internal Medicine2016 · 제31권 제1호

이 간행물의 다른 논문 (12건)